ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3150

Virtual Peer-to-Peer Mentoring Support for Adolescents with Juvenile Idiopathic Arthritis: The Virtual Peer-to-Peer Program

Jennifer N. Stinson1, Sara Ahola Kohut2,3, Khush Amaria2, Mary J. Bell4, Paula Forgeron5, Miriam Kaufman6, Nadia Luca7 and Lynn R. Spiegel8, 1Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 2Hospital for Sick Children, Toronto, ON, Canada, 3University of Toronto, Toronto, ON, Canada, 4Rheum Div/Univ of Toronto, University of Toronto, Toronto, ON, Canada, 5University of Ottawa, Ottawa, ON, Canada, 6Adolescent Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 7Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 8Rheumatology/Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adolescence, juvenile idiopathic arthritis (JIA), Self-management, support and technology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

Session Type: ACR/ARHP Combined Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose:

Juvenile Idiopathic Arthritis (JIA) is a common chronic disease that results in physical and emotional symptoms as well as difficulties in social and role functioning that negatively impact health-related quality of life (HRQL). Many youth with JIA are isolated, having never met another person with JIA and most do not receive comprehensive support to develop self-management skills. The Virtual Peer-to-Peer (VP2P) Program aims to fill this gap by providing peer mentoring via the Internet to improve the accessibility and acceptability of self-management programs while providing essential peer support for adolescents with JIA.

Methods:

The VP2P program was developed in a phased approach. First, a needs assessment was completed in youth with JIA. Second, a systematic review of peer support programs for adolescents with chronic disease was conducted in order to highlight essential components of successful peer interventions. Third, the VP2P program was developed for adolescents with JIA, informed by results of the systematic review, and included a 2.5-day peer mentor training session. Fourth, using a waitlist pilot randomized control trial (RCT) design, young adult peer mentors (16-25 years; successfully managing their JIA) were matched to adolescent participants (12-18 years; diagnosed with JIA, English speaking, access to a computer with Internet) to provide peer support (emotional, informational, and appraisal) and education for effective self-management of JIA. All mentors and adolescents met American College of Rheumatology criteria for JIA. Mentors and adolescents connected 10 times over the 8-week study period using Skype video calls. Primary outcomes focused on implementation of the VP2P program and included measures of feasibility and acceptability. Secondary outcomes focused on effectiveness of the VP2P program and included measures of self-management, self-efficacy, pain, social support and HRQL.

Results:

Thirty adolescents (mean age 14.3±1.7 years, range = 12-17 years, 97% female) completed participation in the pilot RCT (intervention n = 16, control n = 14). Primary outcomes: Over half (64%) of adolescents who were approached agreed and consented to participate; 13% dropped out prior to beginning the intervention or did not complete the 10 full sessions; and 70% of participant-mentor pairings completed the program within 2 months. Median program length was 63.5 days. Average call length was twice the required amount with median call lengths of 45.2±17.2 minutes. Participants reported satisfaction with the program and all reported that they would recommend it to a friend. Participants reported median engagement levels of 8/10 (range = 7.5-10). Secondary outcomes: Participants who completed the VP2P program demonstrated significant improvements in their perceived ability to manage JIA (p = 0.04), improvements in social support (p = 0.03) and disease knowledge (p= 0.01) compared to controls.

Conclusion:

The VP2P program is a promising intervention that improves accessibility and acceptability of self-management and peer support treatments for adolescents with JIA. Findings were used to inform a full-scale multi-site RCT of the VP2P program for adolescents with JIA.


Disclosure: J. N. Stinson, None; S. Ahola Kohut, None; K. Amaria, None; M. J. Bell, Janssen Inc., 5; P. Forgeron, None; M. Kaufman, None; N. Luca, None; L. R. Spiegel, None.

To cite this abstract in AMA style:

Stinson JN, Ahola Kohut S, Amaria K, Bell MJ, Forgeron P, Kaufman M, Luca N, Spiegel LR. Virtual Peer-to-Peer Mentoring Support for Adolescents with Juvenile Idiopathic Arthritis: The Virtual Peer-to-Peer Program [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/virtual-peer-to-peer-mentoring-support-for-adolescents-with-juvenile-idiopathic-arthritis-the-virtual-peer-to-peer-program/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/virtual-peer-to-peer-mentoring-support-for-adolescents-with-juvenile-idiopathic-arthritis-the-virtual-peer-to-peer-program/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology